Gene therapy research for kidney diseases

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Genetics

Background:

• Gene therapy has shown success in treating B cell cancers, retinal degeneration, and neuromuscular atrophy.
• Current genetic disease treatments focus on symptom management, often involving polypharmacy with potential adverse effects.
• Gene therapy development for renal cells has significantly lagged behind other organ systems.

Purpose of the Study:

• To review the current state of gene therapy for kidney diseases.
• To systematically describe the advantages and disadvantages of common gene therapy vector systems.
• To provide insights into the potential utility of gene therapy vectors for genetic kidney diseases.

Main Methods:

• Systematic review of gene therapy vector systems.
• Analysis of adenovirus, retrovirus, and adeno-associated virus vectors.
• Evaluation of vector utility for genetic kidney diseases.

Main Results:

• Adenovirus, retrovirus, and adeno-associated virus vectors have been tested for gene therapy.
• Each vector system possesses unique pros and cons influencing their application.
• Recent advancements indicate growing potential for gene therapy in treating kidney diseases.

Conclusions:

• Gene therapy holds promise for addressing the root causes of genetic kidney diseases.
• Further development of gene therapy vectors is crucial for effective renal intervention.
• Adenovirus, retrovirus, and adeno-associated virus vectors are key candidates for future kidney gene therapy strategies.